234 related articles for article (PubMed ID: 31976659)
21. Alternative chelator for ⁸⁹Zr radiopharmaceuticals: radiolabeling and evaluation of 3,4,3-(LI-1,2-HOPO).
Deri MA; Ponnala S; Zeglis BM; Pohl G; Dannenberg JJ; Lewis JS; Francesconi LC
J Med Chem; 2014 Jun; 57(11):4849-60. PubMed ID: 24814511
[TBL] [Abstract][Full Text] [Related]
22.
Sinnes JP; Bauder-Wüst U; Schäfer M; Moon ES; Kopka K; Rösch F
EJNMMI Radiopharm Chem; 2020 Nov; 5(1):28. PubMed ID: 33242189
[TBL] [Abstract][Full Text] [Related]
23. Pyridine-containing octadentate ligand NE3TA-PY for formation of neutral complex with
Chong HS; Chen Y; Kang CS; Sin I; Zhang S; Wang H
J Inorg Biochem; 2021 Aug; 221():111436. PubMed ID: 33971521
[TBL] [Abstract][Full Text] [Related]
24. Macrocyclic complexes of scandium radionuclides as precursors for diagnostic and therapeutic radiopharmaceuticals.
Majkowska-Pilip A; Bilewicz A
J Inorg Biochem; 2011 Feb; 105(2):313-20. PubMed ID: 21194633
[TBL] [Abstract][Full Text] [Related]
25. Promising Scandium Radionuclides for Nuclear Medicine: A Review on the Production and Chemistry up to In Vivo Proofs of Concept.
Huclier-Markai S; Alliot C; Kerdjoudj R; Mougin-Degraef M; Chouin N; Haddad F
Cancer Biother Radiopharm; 2018 Oct; 33(8):316-329. PubMed ID: 30265573
[TBL] [Abstract][Full Text] [Related]
26. Scandium(III) complexes of monophosphorus acid DOTA analogues: a thermodynamic and radiolabelling study with (44)Sc from cyclotron and from a (44)Ti/(44)Sc generator.
Kerdjoudj R; Pniok M; Alliot C; Kubíček V; Havlíčková J; Rösch F; Hermann P; Huclier-Markai S
Dalton Trans; 2016 Jan; 45(4):1398-409. PubMed ID: 26675416
[TBL] [Abstract][Full Text] [Related]
27. Comparison of the octadentate bifunctional chelator DFO*-pPhe-NCS and the clinically used hexadentate bifunctional chelator DFO-pPhe-NCS for
Vugts DJ; Klaver C; Sewing C; Poot AJ; Adamzek K; Huegli S; Mari C; Visser GWM; Valverde IE; Gasser G; Mindt TL; van Dongen GAMS
Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):286-295. PubMed ID: 27573793
[TBL] [Abstract][Full Text] [Related]
28. H
Wang X; Jaraquemada-Peláez MG; Rodríguez-Rodríguez C; Cao Y; Buchwalder C; Choudhary N; Jermilova U; Ramogida CF; Saatchi K; Häfeli UO; Patrick BO; Orvig C
J Am Chem Soc; 2018 Nov; 140(45):15487-15500. PubMed ID: 30394734
[TBL] [Abstract][Full Text] [Related]
29.
Li L; Rousseau J; Jaraquemada-Peláez MG; Wang X; Robertson A; Radchenko V; Schaffer P; Lin KS; Bénard F; Orvig C
Bioconjug Chem; 2021 Jul; 32(7):1348-1363. PubMed ID: 32216377
[TBL] [Abstract][Full Text] [Related]
30. Gallium Complexation, Stability, and Bioconjugation of 1,4,7-Triazacyclononane Derived Chelators with Azaheterocyclic Arms.
Schmidtke A; Läppchen T; Weinmann C; Bier-Schorr L; Keller M; Kiefer Y; Holland JP; Bartholomä MD
Inorg Chem; 2017 Aug; 56(15):9097-9110. PubMed ID: 28742337
[TBL] [Abstract][Full Text] [Related]
31. Rational Design, Synthesis and Preliminary Evaluation of Novel Fusarinine C-Based Chelators for Radiolabeling with Zirconium-89.
Zhai C; He S; Ye Y; Rangger C; Kaeopookum P; Summer D; Haas H; Kremser L; Lindner H; Foster J; Sosabowski J; Decristoforo C
Biomolecules; 2019 Mar; 9(3):. PubMed ID: 30845658
[TBL] [Abstract][Full Text] [Related]
32. Rapid Thermodynamically Stable Complex Formation of [
Kostelnik TI; Wang X; Southcott L; Wagner HK; Kubeil M; Stephan H; Jaraquemada-Peláez MG; Orvig C
Inorg Chem; 2020 May; 59(10):7238-7251. PubMed ID: 32337985
[TBL] [Abstract][Full Text] [Related]
33. Preclinical Evaluation of a Tailor-Made DOTA-Conjugated PSMA Inhibitor with Optimized Linker Moiety for Imaging and Endoradiotherapy of Prostate Cancer.
Benešová M; Schäfer M; Bauder-Wüst U; Afshar-Oromieh A; Kratochwil C; Mier W; Haberkorn U; Kopka K; Eder M
J Nucl Med; 2015 Jun; 56(6):914-20. PubMed ID: 25883127
[TBL] [Abstract][Full Text] [Related]
34. Phosphinic acid functionalized polyazacycloalkane chelators for radiodiagnostics and radiotherapeutics: unique characteristics and applications.
Notni J; Šimeček J; Wester HJ
ChemMedChem; 2014 Jun; 9(6):1107-15. PubMed ID: 24700633
[TBL] [Abstract][Full Text] [Related]
35. Radiolabeling of DOTATOC with the long-lived positron emitter 44Sc.
Pruszyński M; Majkowska-Pilip A; Loktionova NS; Eppard E; Roesch F
Appl Radiat Isot; 2012 Jun; 70(6):974-9. PubMed ID: 22464928
[TBL] [Abstract][Full Text] [Related]
36. Development of bone seeker radiopharmaceuticals by Scandium-47 and estimation of human absorbed dose.
Deilami-Nezhad L; Moghaddam-Banaem L; Sadeghi M
Appl Radiat Isot; 2017 Nov; 129():108-116. PubMed ID: 28843158
[TBL] [Abstract][Full Text] [Related]
37. A shortcut to high-affinity Ga-68 and Cu-64 radiopharmaceuticals: one-pot click chemistry trimerisation on the TRAP platform.
Baranyai Z; Reich D; Vágner A; Weineisen M; Tóth I; Wester HJ; Notni J
Dalton Trans; 2015 Jun; 44(24):11137-46. PubMed ID: 25999035
[TBL] [Abstract][Full Text] [Related]
38. Homologous Structural, Chemical, and Biological Behavior of Sc and Lu Complexes of the Picaga Bifunctional Chelator: Toward Development of Matched Theranostic Pairs for Radiopharmaceutical Applications.
Vaughn BA; Koller AJ; Chen Z; Ahn SH; Loveless CS; Cingoranelli SJ; Yang Y; Cirri A; Johnson CJ; Lapi SE; Chapman KW; Boros E
Bioconjug Chem; 2021 Jul; 32(7):1232-1241. PubMed ID: 33284001
[TBL] [Abstract][Full Text] [Related]
39. Developments toward the Implementation of
van der Meulen NP; Hasler R; Talip Z; Grundler PV; Favaretto C; Umbricht CA; Müller C; Dellepiane G; Carzaniga TS; Braccini S
Molecules; 2020 Oct; 25(20):. PubMed ID: 33066650
[No Abstract] [Full Text] [Related]
40. Development of Novel PSMA Ligands for Imaging and Therapy with Copper Isotopes.
Carlos Dos Santos J; Beijer B; Bauder-Wüst U; Schäfer M; Leotta K; Eder M; Benešová M; Kleist C; Giesel F; Kratochwil C; Kopka K; Haberkorn U; Mier W
J Nucl Med; 2020 Jan; 61(1):70-79. PubMed ID: 31541034
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]